Cell Therapeutics Sued Over 'False' New Drug Filings
By Nick Malinowski ( March 22, 2010, 3:59 PM EDT) -- Biopharmaceutical company Cell Therapeutics Inc. and its executives have been hit with a putative class action accusing the drugmaker of misleading investors about testing and U.S. Food and Drug Administration fast-track approval for a new treatment product for aggressive non-Hodgkin's lymphoma....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.